These data indicated that the cells surviving after doxorubicin treatment expressed a high amount the MDR1 and RPN2 gene products, suggesting that the development of drug resistance might correlate with induction of their expression in osteosarcoma cells. Here, RPN2 is linked to osteosarcoma.